People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news release Thursday. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The results are on par … Read more

Experimental new drug could revolutionize pancreatic cancer treatment, doctors say

IE 11 is not supported. For an optimal experience visit our site on another browser. Military families call out healthcare company 05:58 Now Playing Experimental new drug could revolutionize pancreatic cancer treatment, doctors say 02:03 UP NEXT Walmart, Aldi Recall Frozen Pizzas Over Salmonella Concerns 00:27 Skin Cancer Prevention Tips: Self-Examination, Sunscreen, More 04:00 FDA … Read more

Experimental treatment for pancreatic cancer could be breakthrough for patients

IE 11 is not supported. For an optimal experience visit our site on another browser. Iran declares Strait of Hormuz closed in response to U.S. Navy blockade 02:14 Trump shifts message on Iran war 02:03 Now Playing Experimental treatment for pancreatic cancer could be breakthrough for patients 02:12 UP NEXT Air travel costs soar heading … Read more

Scientist whose mother and sisters died of ALS complications hopes experimental treatment will save his life

Jeff Vierstra’s mother and two sisters all died following complications from ALS, or Amyotrophic Lateral Sclerosis, but the scientist and skier is hoping an experimental treatment and the first known attempt to prevent the neurodegenerative disease can help save his life. Vierstra was only two years old when his mother died. All her siblings also … Read more

Experimental treatments brings hope to ALS patients

“CBS Saturday Morning” looks at an experimental treatment for amyotrophic lateral sclerosis, or Lou Gehrig’s disease, that is bringing hope to some patients suffering from the neurodegenerative disease. To inquire about possible participation in Silence ALS, an initiative to develop individualized gene-based therapies for patients with other rare genetic forms of ALS, please write to … Read more